 New Funding Opportunity Supports Administrative Supplement for Research on the Health of U3 Women Populations
ORWH released Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional). This NOSI announces the availability of administrative supplements to support research highlighting health inequities among populations of women in the United States that are understudied, underrepresented, and underreported (U3) in biomedical research. Learn more.
|
Read In the Spotlight Articles
 The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
(RFA-OD-22-028)
Application due date: December 19, 2022
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
(RFA-OD-22-015)
AIDS Application due date: January 7, 2023
Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)
(NOT-OD-22-030)
Application due date: January 26, 2023
NOSI: Supporting Women’s Health Research in IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase 1 Program
(NOT-GM-23-012)
Application due date: January 30, 2023
NOSI: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
(NOT-OD-22-208)
Application due date: January 31, 2023
NOSI: Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative
(NOT-HD-22-043)
Application due date: February 6, 2023
|
